Seroprevalence of <i>Toxoplasma gondii</i> in Women Who Have Aborted in Comparison with the Women with Normal Delivery in Ahvaz, Southwest of Iran

Saki, J.; Mohammadpour, N.; Moramezi, F.; Khademvatan, S.

doi:https://doi.org/10.1155/2015/764369

The Scientific World Journal

On this page

Abstract Introduction Materials and Methods Results and Discussion Conclusions Acknowledgments References Copyright Related Articles

Research Article | Open Access

Volume 2015 | Article ID 764369 | https://doi.org/10.1155/2015/764369

Seroprevalence of Toxoplasma gondii in Women Who Have Aborted in Comparison with the Women with Normal Delivery in Ahvaz, Southwest of Iran

J. Saki,¹N. Mohammadpour,²F. Moramezi,³and S. Khademvatan^4,5

Academic Editor: Geoff Hide

Received05 Jul 2014

Revised26 Dec 2014

Accepted12 Jan 2015

Published29 Jan 2015

Abstract

Toxoplasma gondii is an obligate intracellular protozoan parasite causing toxoplasmosis in animals and humans. Primary maternal infection with toxoplasmosis during pregnancy is frequently associated with transplacental transmission to the fetus. However it is not certain whether Toxoplasma infection can cause recurrent abortion. The aim of this study was to determine the relationship between Toxoplasma infection and abortion via detection of anti-Toxoplasma gondii antibodies in sera of women with obstetrical problems and compare the results with control group consisting of women with history of normal delivery. Sera from 130 women with abortion and sera of 130 women with normal delivery were tested for IgG and IgM anti-Toxoplasma gondii antibodies by ELISA method. The present study revealed 24.6% of the samples with abortion and 21.5% of the samples with normal delivery were positive for IgG antibodies. However, statistical analysis indicated no significant differences . In addition, IgM antibody was detected in one woman who had aborted but not in women with normal childbirth. This study showed no significant difference between the case and control groups in IgG anti-Toxoplasma antibody but detected one sample with IgM antibodies in woman with abortion during the first trimester of pregnancy. In order to determine the relationship between Toxoplasma infection and abortion, anti-Toxoplasma IgG avidity and PCR to discriminate between recent and prior infections are recommended.

1. Introduction

Toxoplasma gondii is an obligate intracellular protozoan parasite responsible for animal and human toxoplasmosis and one of the most common chronic diseases affecting one-third of the world’s human population [1]. The seroepidemiological evaluations indicate that toxoplasmosis is one of the most prevalent human diseases in many countries [2]. Transmission of T. gondii is usually by ingestion of cysts infected and undercooked or raw meat or by accidental ingestion of oocysts that may contaminate soil, water, and food. Meat is one of the most important sources of the infection in individuals [3].

Toxoplasmosis is also one of the infections that can be transmitted through placenta during pregnancy [2]. Although toxoplasmosis is largely asymptomatic in the majority of women, primary infection during pregnancy can result in disease transmission through the placenta and lead to hazardous consequences such as abortion, stillbirth, different degrees of mental or physical retardation, hydrocephalus, and blindness [2, 4, 5]. The seroprevalence of T. gondii antibodies in pregnant women can vary from 6.1 to 75.2% based on the geographical region [2]. Congenital toxoplasmosis can occur as a primary infection acquired during pregnancy [6], but not from the reactivation of a latent infection in immune competent pregnant women [7]. Several studies have suggested the role of T. gondii in the causation of abortions. Several serological assays have detected the immunoglobulin (IgG and IgM) antibodies against T. gondii in the serum. Among the assays, ELISA shows high sensitivity and specificity. In Ahvaz city southwest Iran, the incidence of IgG and IgM anti-Toxoplasma antibodies in women with high risk pregnancies and habitual abortion has not been documented. Therefore the presence of anti-T. gondii antibodies in cases of normal delivery and abortions, referred to the Teaching Hospital of Ahvaz Jundishapur University of Medical Sciences, was investigated, with the aim to determine the relationship between Toxoplasma infection and abortion.

2. Materials and Methods

The women admitted to the Gynecology Clinic of Ahvaz Imam Khomeini Teaching Hospital, affiliated to Jundishapur University of Medical Sciences, from April 2012 to March 2013 were included in this case control study. In this study the blood samples were prepared from two groups (study group and control group). The study group were women who had been referred to hospital because of abortion and for treatment and the control group were women who had normal delivery and were referred to hospital for a checkup.

The blood samples were collected from case group (patients) including 130 women with abortion and from the control group including 130 women with normal delivery and serum separated. ELISA (Trinity, Biotech, USA) was used for detection of anti-Toxoplasma IgG and IgM antibodies in the case and control groups. The results were analyzed using the SPSS software version 16 and -test and chi square statistical tests. Value less than 0.05 was considered as statistically significant.

3. Results and Discussion

Out of 130 women with abortion, 32 (24.6%) and, out of 130 women with normal delivery, 28 (21.5%) were positive for IgG antibody against T. gondii. However, statistical analysis indicated no significant differences (). In addition, IgM antibody was detected in one woman who had aborted but not in women with normal childbirth. Comparison of average antibody titer in the case and control groups showed no statistical significant differences (). In regard to the trimesters of pregnancy, for the case group during the first trimester of pregnancy there was 8/30 (26.66%) IgG seropositive, and 1/30 (3.33%) was IgM positive; in the second trimester 6/40 (15%) were IgG positive and in the third trimester of pregnancy 17/60 (28.3%) were IgG positive. No samples of second and third trimesters of the case group had IgM positive results. For the control group during the first trimester of pregnancy there was 7/33 (21.21%) IgG seropositive; in the second trimester 5/37 (13.51%) were IgG positive and in the third trimester of pregnancy 16/62 (25.8%) were IgG positive. No samples of the control group had IgM positive results.

Out of 32 positive cases, 19 and 13 patients were urban and rural, respectively.

Early diagnosis of acute toxoplasmosis during pregnancy is needed for assessment of vertical transmission risk of infections and prevention of related severe complications.

Seroprevalence study showed Toxoplasma infection in pregnant women is between 7 and 51.3% throughout the world and the results of anti-Toxoplasma antibodies in women with abnormal pregnancy varied from 17.5 to 52.3% [8].

In women with acute toxoplasmosis, Toxoplasma transmission rate through placenta in the first, second, and third trimesters is 25, 54, and 65%, respectively, and early diagnosis and specific treatment of mothers can reduce the risk of fetal infection up to 50% [9].

In many studies, contaminated drinking water and close contact with cats have been implicated as sources of Toxoplasma infection in humans worldwide [10–14]. However no statistically significant association between these risk factors and Toxoplasma seropositivity was observed in the current study. In regard to location, the prevalence rate of IgG anti-Toxoplasma gondii antibodies in women with abortion was 19/90 (21.1%) and 13/40 (32.5%) for urban and rural cases, respectively, which indicated significant differences (). The possible reason for this difference is the more contact with soil in rural individuals in comparison with urban ones.

Diagnosis of T. gondii infection before conception is very essential especially in population with low seroprevalence rate but is usually not possible and therefore testing for antibodies to Toxoplasma in pregnancy is performed only in suspected cases. This study showed that the prevalence of IgG antibody was 24.6% in women with abortion and 21.5% in the control group; however, this difference was not statistically significant. In addition IgM antibody was detected in one woman who had aborted but not in women with normal childbirth.

Nimri et al. [15] reported that IgG results of the cases differed significantly from those of the controls (54% and 12% resp.; ). In addition 2.7% of the cases were IgM positive, in the test group.

Ebadi et al. [16] in seroprevalence study in Jahrom, Iran, revealed a higher prevalence of anti-Toxoplasma IgG antibody in women with repeated abortions (17.5%) compared with the control group (14%); however, the difference was not statistically significant.

Sharif and Ajami [17] reported the frequency of anti-Toxoplasma IgG and IgM in women with a history of abortion or stillbirth in Sari to be 34.21% and 7.89%, respectively. In 2007 [18], in Bandar Abbas, south Iran, 124 women with a history of abortion were evaluated for the frequency of anti-Toxoplasma IgG and IgM. It was found that 98 (79.03%) and 19 (15.32%) patients were positive for IgG and IgM, respectively.

Saeedi et al. [19] showed that the frequency of anti-Toxoplasma antibodies among the women with normal and abnormal pregnancy was, respectively, 45.5% and 44.1% for IgG () and 46.5% and 21% for IgM (), with significant relationship observed only between abortion and IgM titers.

Study conducted in Kashmir by Zargar et al. [20] in 1998 revealed the prevalence of IgM anti-Toxoplasma antibody in women with recurrent abortion (49.47%), which was more than the control group with normal delivery (8.88%); they suggested a probable relationship between Toxoplasma infection and recurrent abortion. Bobic et al. [21] in 1991 showed that the prevalence of IgG and IgM antibodies in women with uncomplicated abortion is 44.9% and 33.3%, respectively.

4. Conclusions

Although no statistical significant differences of IgG anti-Toxoplasma gondii prevalence were observed between the case and control groups in this study, detection of IgM antibody in a woman who had abortion indicates the possible role of Toxoplasma gondii in abortion phenomenon in the region. Because studies show IgM antibodies may persist for 1 year after infection and the positive result for the antibodies must be interpreted with caution [22, 23]. In order to improve the diagnosis of primary infection with T. gondii in pregnancy using anti-Toxoplasma IgG avidity and PCR which have the ability to discriminate between recent and prior infections are recommended [24].

Conflict of Interests

The authors wish to declare that there is no known conflict of interests associated with this paper and there have been no competing financial interests.

Funding

Research Deputy, Ahvaz Jundishapur University of Medical Sciences.

Acknowledgments

This study is conducted and financially supported by Grant (no. OG-93110) from Research Deputy of Ahvaz Jundishapur University of Medical Sciences, Iran. The authors would like to kindly appreciate cooperation of the Gynecology Clinic of Ahvaz Imam Khomeini Teaching Hospital staff for the period of sampling.

References

J. L. Jones, D. Kruszon-Moran, M. Wilson, G. McQuillan, T. Navin, and J. B. McAuley, “Toxoplasma gondii infection in the United States: seroprevalence and risk factors,” American Journal of Epidemiology, vol. 154, no. 4, pp. 357–365, 2001.
View at: Publisher Site | Google Scholar
H. M. Elsheikha, “Congenital toxoplasmosis: priorities for further health promotion action,” Public Health, vol. 122, no. 4, pp. 335–353, 2008.
View at: Publisher Site | Google Scholar
J. P. Dubey, D. E. Hill, J. L. Jones et al., “Prevalence of viable Toxoplasma gondii in beef, chicken, and pork from retail meat stores in the United States: risk assessment to consumers,” Journal of Parasitology, vol. 91, no. 5, pp. 1082–1093, 2005.
View at: Publisher Site | Google Scholar
P. Ambroise-Thomas and E. Petersen, “Congenital toxoplasmosis,” in Scientific Background, Clinical Managment and Control, Springer, Paris, France, 2000.
View at: Google Scholar
J. G. Montoya and O. Liesenfeld, “Toxoplasmosis,” The Lancet, vol. 363, no. 9425, pp. 1965–1976, 2004.
View at: Publisher Site | Google Scholar
J. G. Montoya, O. Liesenfeld, S. Kinney, C. Press, and J. S. Remington, “VIDAS test for avidity of toxoplasma-specific immunoglobulin G for confirmatory testing of pregnant women,” Journal of Clinical Microbiology, vol. 40, no. 7, pp. 2504–2508, 2002.
View at: Publisher Site | Google Scholar
N. Vogel, M. Kirisits, E. Michael et al., “Congenital toxoplasmosis transmitted from an immunologically competent mother infected before conception,” Clinical Infectious Diseases, vol. 23, no. 5, pp. 1055–1060, 1996.
View at: Publisher Site | Google Scholar
L. Galván Ramírez M de la, J. L. Soto Mancilla, O. Velasco Castrejón, and R. Pérez Medina, “Incidence of anti-Toxoplasma antibodies in women with high-risk pregnancy and habitual abortions,” Revista da Sociedade Brasileira de Medicina Tropical, vol. 28, no. 4, pp. 333–337, 1995.
View at: Publisher Site | Google Scholar
B. J. Freij and J. L. Sever, “Toxoplasmosis,” Pediatrics in Review, vol. 12, no. 8, pp. 227–236, 1991.
View at: Publisher Site | Google Scholar
Y. Sukthana, T. Chintana, S. Damrongkitchaiporn, and A. Lekkla, “Serological study of Toxoplasma gondii in kidney recipients,” Journal of the Medical Association of Thailand, vol. 84, no. 8, pp. 1137–1141, 2001.
View at: Google Scholar
M. R. Wallace, R. J. Rossetti, and P. E. Olson, “Cats and toxoplasmosis risk in HIV-infected adults,” The Journal of the American Medical Association, vol. 269, no. 1, pp. 76–77, 1993.
View at: Publisher Site | Google Scholar
C. Magaldi, H. Elkis, D. Pattoli, and A. L. Coscina, “Epidemic of toxoplasmosis at a university in São-José-dos Campos, S.P. Brazil. 1. Clinical and serologic data,” Revista latinoamericana de microbiologia y parasitologia, vol. 11, no. 1, pp. 5–13, 1969.
View at: Google Scholar
W.-Y. Choi, H.-W. Nam, N.-H. Kwak et al., “Foodborne outbreaks of human toxoplasmosis,” Journal of Infectious Diseases, vol. 175, no. 5, pp. 1280–1282, 1997.
View at: Publisher Site | Google Scholar
Y.-L. Lin, Y.-S. Liao, L.-R. Liao, F.-N. Chen, H.-M. Kuo, and S. He, “Seroprevalence and sources of Toxoplasma infection among indigenous and immigrant pregnant women in Taiwan,” Parasitology Research, vol. 103, no. 1, pp. 67–74, 2008.
View at: Publisher Site | Google Scholar
L. Nimri, H. Pelloux, and L. Elkhatib, “Detection of Toxoplasma gondii DNA and specific antibodies in high-risk pregnant women,” The American Journal of Tropical Medicine and Hygiene, vol. 71, no. 6, pp. 831–835, 2004.
View at: Google Scholar
P. Ebadi, K. Solhjoo, K. Bagheri, and F. Eftekhar, “Seroprevalence of toxoplasmosis among the women with recurrent spontaneous abortion in comparison with the women with uncomplicated delivery,” Journal of Jahrom University of Medical Sciences, vol. 9, no. 1, pp. 32–36, 2011.
View at: Google Scholar
M. Sharif and A. Ajami, “Serological survey of toxoplasmosis in women with abortion or still birth referring to women clinic in Sari, 1997-1998,” Journal of Mazandaran University of Medical Science, vol. 26, pp. 13–18, 1999.
View at: Google Scholar
A. S. Jahromi, “Anti-toxoplasma antibodies in women with abortion or still birth,” Journal of Jahrom University of Medical Science, vol. 4, pp. 47–52, 2007.
View at: Google Scholar
M. Saeedi, S. B. Nosrat, A. Moradi, S. M. H. Mofidi, and N. Behnampoor, “Comparative study of Cytomegalovirus, Listeria monocytogen and Toxoplasma gondii infections in successful and non-successful pregnancy in Gorgan,” Medical Laboratory Journal, vol. 3, no. 1, pp. 25–30, 2009 (Persian).
View at: Google Scholar
A. H. Zargar, S. R. Masoodi, B. A. Laway, B. A. Sofi, and A. I. Wani, “Seroprevalence of toxoplasmosis in women with repeated abortions in Kashmir,” Journal of Epidemiology and Community Health, vol. 52, no. 2, pp. 135–136, 1998.
View at: Publisher Site | Google Scholar
B. Bobic, D. Sibalic, and O. Djurkovic-Djakovic, “High levels of IgM antibodies specific for Toxoplasma gondii in pregnancy 12 years after primary toxoplasma infection. Case report,” Gynecologic and Obstetric Investigation, vol. 31, no. 3, pp. 182–184, 1991.
View at: Publisher Site | Google Scholar
J. M. Francis and D. H. M. Joynson, “Duration of specific immunoglobulin A antibody following acute toxoplasmosis as determined by enzyme immunoassay and immunosorbent agglutination assay,” European Journal of Clinical Microbiology and Infectious Diseases, vol. 12, no. 7, pp. 556–559, 1993.
View at: Publisher Site | Google Scholar
H. Pelloux, E. Brun, G. Vernet et al., “Determination of anti-Toxoplasma gondii immunoglobulin G avidity: adaptation to the Vidas system (BioMerieux),” Diagnostic Microbiology and Infectious Disease, vol. 32, no. 2, pp. 69–73, 1998.
View at: Publisher Site | Google Scholar
P. A. Jenum, B. Stray-Pedersen, and A.-G. Gundersen, “Improved diagnosis of primary Toxoplasma gondii infection in early pregnancy by determination of antitoxoplasma immunoglobulin G avidity,” Journal of Clinical Microbiology, vol. 35, no. 8, pp. 1972–1977, 1997.
View at: Google Scholar

Copyright

Copyright © 2015 J. Saki et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation

Download other formats

Order printed copies

Views

3877

Downloads

1717

Citations